Vaginitis Menopause

Scheidenentzündungen treten in den Wechseljahren deutlich häufiger auf – meist verursacht durch hormonelle Veränderungen. Der sinkende Östrogenspiegel führt zu einer dünneren, trockeneren Schleimhaut und zu einem gestörten Scheidenmilieu. Diese Veränderungen begünstigen das Entstehen der sogenannten atrophischen Kolpitis. Typische Symptome wie Brennen, Trockenheit, Schmerzen beim Geschlechtsverkehr oder häufige Infekte werden oft nicht mit einer entzündlichen Grunderkrankung in Verbindung gebracht – und bleiben daher unbehandelt. Die Therapie reicht von lokalen Östrogenpräparaten über milde Pflege mit Hyaluronsäure bis hin zu innovativen Medizinprodukten wie CANNEFF® Vaginalzäpfchen mit CBD und Hyaluronsäure. Auch Milchsäurekuren und Probiotika tragen zur Stabilisierung des Scheidenmilieus bei. Dieser Beitrag zeigt, wie man Scheidenentzündungen in der Menopause sicher erkennt, was wirklich hilft – und wann eine Hormontherapie sinnvoll sein kann. Ein ganzheitlicher Therapieansatz ist entscheidend für nachhaltige Linderung und die Wiederherstellung der vaginalen Gesundheit.
Philip Schmiedhofer, MSc

Autor

Philip Schmiedhofer, MSc

Inhaltsverzeichnis

Why do vaginal infections occur more frequently during menopause?

At the onset of menopause, the hormonal balance in the female body changes fundamentally.

What role does estrogen deficiency play in colpitis?

Estrogen is the central hormone for maintaining vaginal health.

What helps with atrophic colpitis during menopause?

In atrophic colpitis, caring, moisturizing, and regenerating measures are the main focus.

How do symptoms during menopause differ from normal infections?

The symptoms of colpitis during menopause often differ from classic signs of infection.

What hormone-free therapies are available for vaginal inflammation during menopause?

For women who do not want or cannot tolerate hormone therapy, effective hormone-free options are now available.

Can CANNEFF® suppositories with CBD and hyaluronic acid provide relief?

CANNEFF® vaginal suppositories with CBD and hyaluronic acid represent an innovative, plant-based option for relieving vaginal discomfort during menopause.

How can the vaginal flora be sustainably stabilized during menopause?

A sustainable stabilization of the vaginal flora during menopause is based on three principles: moisture supply, development of the lactobacillus flora, and protection of the mucous membrane.

What risks are associated with untreated colpitis after menopause?

Untreated colpitis after menopause can have far-reaching consequences.

Which herbal remedies help with estrogen deficiency in the intimate area?

For hormonally induced vaginal dryness and mucosal atrophy, herbal remedies offer gentle support.

When is hormone therapy useful for vaginal inflammation?

A local hormone therapy with estrogen is advisable when atrophic colpitis has been diagnosed, which severely restricts comfort and hormone-free measures alone are not sufficient.

Why do vaginal inflammations occur more frequently during menopause?

At the onset of menopause, the hormonal balance in the female body changes fundamentally. The decline in estrogen also affects the vaginal tissue, which becomes increasingly thinner, drier, and less well supplied with blood. These changes lead to a decrease in the natural protective mechanisms of the vagina. The acidic vaginal environment, maintained by lactic acid bacteria, loses stability – pathogenic germs can settle more easily. Additionally, the elasticity of the mucous membrane decreases, which promotes micro-injuries. Combined with a reduced local immune defense, this explains why vaginal inflammations occur significantly more often in postmenopause.

Vaginal inflammation menopause estrogen

What role does estrogen deficiency play in colpitis?

Estrogen is the central hormone for maintaining vaginal health. It promotes blood circulation, ensures a dense, stable mucous membrane layer, and increases sugar production in the cells, providing sufficient nourishment for lactic acid bacteria. In estrogen deficiency – as occurs during menopause or after surgical removal of the ovaries – the tissue shrinks, and the mucous membrane becomes more susceptible to irritation, infections, and inflammation. This form of colpitis is medically referred to as atrophic colpitis or Senile colpitis is described. The mucous membrane is not primarily infected but is inflamed and irritated due to its structural degeneration.

What helps with atrophic colpitis during menopause?

In atrophic colpitis, caring, moisturizing, and regenerating measures are the focus. In basic therapy, locally acting estrogens are used, usually in the form of creams, vaginal tablets, or suppositories. These preparations improve the mucous membrane structure and promote the regeneration of lactobacilli. For women who want or need to avoid hormones, hormone-free alternatives such as Hyaluronic acid suppositories, plant-based preparations with phytoestrogens or Suppositories with cannabidiol (CBD) and hyaluronic acid makes sense. Especially in long-term care, combinations of moisturizing and anti-inflammatory ingredients prove effective.

Type of therapy

Effect

Suitable for

Local estrogens

Mucous membrane restoration, pH stabilization

Severe atrophic colpitis

CANNEFF® suppositories

Anti-inflammatory, moisture, regeneration

Mild to moderate symptoms

Lactic acid preparations

Flora restoration, pH reduction

Prevention and aftercare

Phytoestrogens

Mild hormone replacement, mucous membrane support

Hormone replacement alternative

Probiotics (vaginal/oral)

Microbiome stabilization

Relapse prevention after antibiotics

Vaginal inflammation menopause symptoms

How do symptoms during menopause differ from normal infections?

The symptoms of colpitis during menopause often differ from classic signs of infection. While bacterial or fungal infections typically involve itching, altered discharge, or an unpleasant odor, women affected by atrophic colpitis more often complain of dry mucous membranes, Burning, pain during sexual intercourse and a Foreign body sensation. The discharge is usually minimal, not purulent, but clear to whitish. These nonspecific symptoms make diagnosis difficult and often lead to late treatment – although early therapy can significantly improve quality of life.

What hormone-free therapies are available for vaginal inflammation during menopause?

For women who do not want or cannot tolerate hormone therapy, effective hormone-free options are now available. These include Hyaluronic acid suppositoriesthat moisturize the mucous membrane and promote healing, as well as products with plant-based ingredients such as chamomile, marigold, or evening primrose oil. Especially valuable are CANNEFF® Suppositories with Cannabidiol (CBD), which have anti-inflammatory, soothing, and antioxidant effects. Additionally, they can Lactic acid preparations help stabilize the vaginal environment and build up the vaginal flora. A individually tailored combination of these approaches can effectively relieve symptoms – completely without synthetic hormones.

Can CANNEFF® suppositories with CBD and hyaluronic acid provide relief?

CANNEFF® vaginal suppositories with CBD and Hyaluronic Acid represent an innovative, plant-based option for relieving vaginal discomfort during menopause. CANNEFF® has anti-inflammatory, antioxidant, and anti-itch effects. CANNEFF® ensures that the mucous membranes are intensely moisturized and supports their regeneration. Especially with atrophic colpitis, mucous membrane irritations, pain during sex, or after infections, CANNEFF® suppositories can sustainably improve vaginal health. The plant-based formula without hormones also makes them suitable for women who do not want or cannot tolerate systemic hormone therapy. Their use is especially recommended for chronic irritation or as long-term care. Furthermore, clinical studies with menopausal women have shown that daily use of CANNEFF® vaginal suppositories can relieve other physiological symptoms of menopause. These include hot flashes, sleep disorders, joint pain, inner restlessness, and depressive moods.

How to sustainably stabilize the vaginal flora during menopause?

Sustainable stabilization of the vaginal flora during menopause is based on three principles: moisture supply, rebuilding the lactobacillus flora, and protecting the mucous membrane. Suitable for this are lactic acid suppositories, probiotic vaginal preparations as well as regular applications with Hyaluronic acid and CBD. A targeted diet with prebiotic fiber, low sugar, and sufficient omega-3 fatty acids can also positively influence the microbiome. Physical activity, stress reduction, and good intimate hygiene without irritating products are also important. Close cooperation with the gynecologist helps develop the individually suitable strategy for long-term stabilization.

What risks exist with untreated colpitis after menopause?

Untreated colpitis during and after menopause can have far-reaching consequences. The dry, fragile mucous membrane is susceptible to tears, infections, and chronic irritations. As a result of constant inflammatory processes, it can lead to scarring, vaginal narrowing and pain during sexual intercourse occur. The risk of ascending urinary tract infections increases significantly because the anatomical barriers are weakened. In rare cases, chronic irritation promotes the development of precancerous changes. To avoid these complications, early treatment of atrophic colpitis is very important – even if only mild symptoms initially appear.

Which herbal remedies help with estrogen deficiency in the intimate area?

For hormonally induced vaginal dryness and mucous membrane degradation, offer herbal remedies a gentle support. Especially Phytoestrogens from red clover, soy, or black cohosh can have mild estrogen-like effects and positively influence the mucous membrane structure. Also Calendula, evening primrose oil and Chamomile are used in intimate care products because they have soothing, anti-inflammatory, and wound-healing effects. Herbal suppositories like CANNEFF® combine these effects with modern active ingredients such as CBD and Hyaluronic Acid, which work without hormonal effects but specifically support regeneration. These options are especially suitable for women who are not allowed or do not want to receive classic hormone therapy.

Vaginal inflammation menopause hormones

When is hormone therapy useful for vaginal inflammation?

A local hormone therapy with estrogen is useful when atrophic colpitis has been diagnosed, which severely restricts symptoms and hormone-free measures alone are not sufficient. Vaginal application is low-risk as it hardly produces systemic effects. After just a few weeks, the mucous membrane structure, blood circulation, and pH values improve significantly. Especially with recurring urinary tract infections, severe dryness, or pain during sexual intercourser, hormone therapy can bring a significant improvement in quality of life. However, contraindications such as breast cancer or thrombosis risk must always be individually assessed. A combination with non-hormonal care products is also possible and sensible for long-term care.

Back to the blog
Philip Schmiedhofer, MSc

Philip Schmiedhofer, MSc

Medical Technician & Neuroscientist

Philip is the managing director and co-founder of cannmedic GmbH. With a degree in medical engineering and molecular biology, specializing in neuroscience and focusing on cannabinoids, he is recognized as an expert in the application of cannabinoids in medicine. As a medical device consultant, he leads the sales of cannmedic and offers specialized advice to medical professionals. His expertise includes the development and sales of cannabinoid-based products. In the field of research, he participates in significant basic research at the Center for Brain Research at the Medical University of Vienna. As co-founder and current managing director of cannhelp GmbH, a pioneer in the CBD sector, he has many years of entrepreneurial experience. Furthermore, he maintains an extensive network in the industry and advises internationally operating companies in the field of medical cannabinoids.